PMGC Holdings (ELAB) Retained Earnings (2022 - 2025)
PMGC Holdings (ELAB) posted Retained Earnings of $28.9 million for Q4 2025, up 2361515.38% sequentially from -$1222.0 in Q2 2025, and up 8562858.46% YoY from N/an in Q4 2024.
PMGC Holdings (ELAB) Retained Earnings (2022 - 2025) Analysis & Trends
PMGC Holdings has reported Retained Earnings for 4 years, with the latest figure at $28.9 million in Q4 2025.
- Quarterly Retained Earnings rose 8562858.46% year-over-year to $28.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28.9 million (up 8562858.46% YoY) and the FY2025 annual result came in at $28.9 million, up 8562858.46% from the prior year.
- Retained Earnings rose to $28.9 million in Q4 2025 per ELAB's latest filing, from -$1222.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $28.9 million in Q4 2025 and troughed at -$5.9 billion in Q3 2023.
- A 4-year average of -$585.3 million and a median of -$576.5 in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings slumped 6327928.83% in 2023, then surged 8562858.46% in 2025.
- Over 4 years, Retained Earnings stood at $111.0 in 2022, then plunged by 6327928.83% to -$7.0 million in 2023, then surged by 100.0% to -$337.0 in 2024, then soared by 8562858.46% to $28.9 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered $28.9 million, -$1222.0, and -$816.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 4.38 Bn |
| 10 | PMGC Holdings | 31.52 Mn | 12.73 Mn | 385,691.00 | 45.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.86 Mn |
| Jun 30, 2025 | -1,222.00 |
| Mar 31, 2025 | -816.00 |
| Dec 31, 2024 | -337.00 |
| Sep 30, 2024 | 228.00 |
| Jun 30, 2024 | 1,242.00 |
| Mar 31, 2024 | -8.42 Mn |
| Dec 31, 2023 | -7.02 Mn |
| Sep 30, 2023 | -5.87 Bn |
| Dec 31, 2022 | 111.00 |